Inspire Medical Systems Faces Securities Lawsuit
Analysis based on 6 articles · First reported Nov 20, 2025 · Last updated Jan 05, 2026
The market is negatively impacted by the significant drop in Inspire Medical Systems' stock price and market capitalization following the setbacks in its Inspire V device launch. This event highlights the risks associated with product launches and the importance of transparent communication from publicly traded companies to investors.
Inspire Medical Systems, Inc. is facing a federal securities class action lawsuit filed by Faruqi & Faruqi, LLP. The lawsuit alleges that Inspire Medical Systems and its executives made false and misleading statements regarding the launch of its Inspire V device. On August 4, 2025, Inspire Medical Systems announced significant setbacks, including delays in treatment center training, contracting, and onboarding, as well as billing and reimbursement challenges related to United States — Medicare's CPT code and software updates. The company also reported weak demand and excess inventory, leading to an over 80% cut in its 2025 earnings guidance. Following these revelations, Inspire Medical Systems' stock price plummeted over 32% in one day, resulting in a loss of approximately $1.2 billion in market capitalization. James Wilson of Faruqi & Faruqi is encouraging affected investors to join the class action lawsuit, with a deadline of January 5, 2026, to seek the role of lead plaintiff.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard